Fidelity Investments’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$451 Sell
149
-60
-29% -$210 ﹤0.01% 5321
2026
Q1
$833 Buy
209
+9
+5% +$40 ﹤0.01% 5114
2025
Q4
$796 Sell
200
-12
-6% -$44 ﹤0.01% 5116
2025
Q3
$666 Sell
212
-20
-9% -$78 ﹤0.01% 5063
2025
Q2
$1.1K Sell
232
-282
-55% -$1.32K ﹤0.01% 4953
2025
Q1
$2.43K Buy
514
+101
+24% +$588 ﹤0.01% 4853
2024
Q4
$2.86K Buy
413
+71
+21% +$520 ﹤0.01% 4754
2024
Q3
$1.98K Hold
342
– – ﹤0.01% 4813
2024
Q2
$1.82K Hold
342
– – ﹤0.01% 4739
2024
Q1
$1.3K Buy
+342
New +$1.24K ﹤0.01% 4759
2022
Q1
– Sell
-517
Closed -$4K – 5451
2021
Q4
$4K Buy
+517
New +$2.83K ﹤0.01% 3873

Other funds holding SRTS

Fidelity Investments's SRTS Position: Q2 2026 in Review

Fidelity Investments reduced its Sensus Healthcare (SRTS) stake by 29% in Q2 2026, selling an estimated $210 and leaving 149 shares worth $451. The position accounts for ﹤0.01% of the portfolio, ranked #5321.

Fidelity Investments first reported a position in SRTS in Q4 2021 and has held it in 11 quarters since. The position peaked at $4K in Q4 2021. 38 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.

  • Fidelity Investments held 149 shares of Sensus Healthcare worth $451 as of Q2 2026.
  • Fidelity Investments sold 60 Sensus Healthcare shares in Q2 2026, an estimated $210.
  • Sensus Healthcare made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5321 holding.
  • Fidelity Investments first reported a position in Sensus Healthcare in Q4 2021 and has held it in 11 quarters since.
  • Fidelity Investments's Sensus Healthcare position peaked at $4K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.